Clinical Trial Update: SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SBRT and oncolytic virus therapy prior to pembrolizumab in metastatic non-small cell lung cancer and metastatic triple-negative breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Oncolytic virus therapy (Oncolytic virus therapy)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Metastatic Non-small Cell Lung Cancer, Metastatic Triple-negative Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-01-25